[go: up one dir, main page]

AR033260A1 - Nueva composicion hormonal y su utilizacion - Google Patents

Nueva composicion hormonal y su utilizacion

Info

Publication number
AR033260A1
AR033260A1 ARP020101475A ARP020101475A AR033260A1 AR 033260 A1 AR033260 A1 AR 033260A1 AR P020101475 A ARP020101475 A AR P020101475A AR P020101475 A ARP020101475 A AR P020101475A AR 033260 A1 AR033260 A1 AR 033260A1
Authority
AR
Argentina
Prior art keywords
compound
estrogenic
association
new
stroprogestative
Prior art date
Application number
ARP020101475A
Other languages
English (en)
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of AR033260A1 publication Critical patent/AR033260A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Dominio de la química terapéutica, y más particularmente dominio de la técnica farmacéutica hormonal. Nuevas composiciones farmacéuticas hormonales formadas por una asociacion estroprogestativa constituida por un compuesto estrogeno y un compuesto progestativo, en asociacion o mezclado con varios excipientes no toxicos, inertes, farmacéuticamente aceptables, destinadas a la administracion por vía bucal.Uso de una mezcla estroprogestativa en que el compuesto estrogénico y el compuesto progestativo se administran de una manera combinada la asociacion combinada puede ser prescripta de una manera continua o intermitente mediante la preparacion de un compuesto destinado al tratamiento de carencias estrogénicas, evitar la osteoporosis y las enfermedades, en la mujer menopáusica. Un procedimiento para la preparacion de estas nuevas composiciones farmacéuticas estroprogestativas.
ARP020101475A 2001-04-25 2002-04-24 Nueva composicion hormonal y su utilizacion AR033260A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105557A FR2823976A1 (fr) 2001-04-25 2001-04-25 Nouvelle composition hormonale et son utilisation

Publications (1)

Publication Number Publication Date
AR033260A1 true AR033260A1 (es) 2003-12-10

Family

ID=8862668

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101475A AR033260A1 (es) 2001-04-25 2002-04-24 Nueva composicion hormonal y su utilizacion

Country Status (9)

Country Link
KR (1) KR20030043797A (es)
CN (1) CN1464787A (es)
AR (1) AR033260A1 (es)
AU (1) AU2002310721A1 (es)
BR (1) BR0205104A (es)
FR (1) FR2823976A1 (es)
MA (1) MA26833A1 (es)
NO (1) NO20026215L (es)
WO (1) WO2002085375A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022053B2 (en) 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
UY29185A1 (es) * 2004-11-02 2006-05-31 Schering Ag Formas de dosificación oral sólidas que contienen una dosis baja de estradiol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation

Also Published As

Publication number Publication date
FR2823976A1 (fr) 2002-10-31
AU2002310721A1 (en) 2002-11-05
MA26833A1 (fr) 2004-12-20
CN1464787A (zh) 2003-12-31
NO20026215D0 (no) 2002-12-23
BR0205104A (pt) 2003-05-20
KR20030043797A (ko) 2003-06-02
NO20026215L (no) 2003-02-21
WO2002085375A8 (fr) 2003-02-20
WO2002085375A1 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
EA200201000A1 (ru) Гормон-заместительная терапия
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
EA200301022A1 (ru) Гормональная заместительная терапия
EA200600964A1 (ru) Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
EA200600029A1 (ru) Фармацевтическая композиция для контрацепции и заместительной гормональной терапии
CR7420A (es) Composiciones farmaceuticas que comprenden uno o varios esteroides, uno o varios componentes de tetrahiidrofolatos y vitamina b12
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
MY128482A (en) New hormonal composition and its use
AP1625A (en) Hormonal composition based on a progesterone and an oestrogen and use thereof.
BR0114665A (pt) Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
ES2303811T1 (es) Uso de anastrozol para el tratamiento post-menopausico de una mujer que tiene cancer de mama temprano.
AR033260A1 (es) Nueva composicion hormonal y su utilizacion
CR6627A (es) Nuevo medicamento contraceptivo y su modo de preparacion
HUP0004461A2 (hu) Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények
AR039227A1 (es) Terapia de reemplazo hormonal
EA201000097A1 (ru) 8-бета-замещенные эстратриены в качестве селективно активных эстрогенов
AR039228A1 (es) Terapia de reemplazo hormonal
JP2005532336A5 (es)
AR039477A1 (es) Terapia de reemplazo hormonal
CR6628A (es) Nueva composicion hormonal y su utilizacion
EP1857110A3 (en) Hormone replacement therapy
HRP20020666B1 (hr) Drospirenon za hormonsku nadomjesnu terapiju
AR044184A1 (es) Metodo para el manejo terapeutico de la proliferacion extrauterina de tejido endometrial, dolor pelvico cronico y obstruccion de las trompas de falopio, las composiciones farmaceuticas utiles para la aplicacion de dicho metodo y el uso de un antagonista de lhrh para la preparacion de dichos medicame

Legal Events

Date Code Title Description
FA Abandonment or withdrawal